Related Experiment Video

Updated: Jul 15, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

Antizyme1 mediates AURKAIP1-dependent degradation of Aurora-A

S K Lim1, G Gopalan

  • 1Laboratory of Gene Structure and Expression, Division of Molecular and Cellular Research, National Cancer Centre, Singapore, Singapore.

Oncogene
|April 25, 2007
PubMed

Insights

Aurora-A oncogene stability is regulated by antizyme1 (Az1) via a proteasome-dependent, but ubiquitin-independent pathway. Aurora-A kinase interacting protein 1 (AURKAIP1) enhances Az1 binding to Aurora-A, promoting its degradation.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Protein Degradation

Background:

  • Aurora-A oncogene overexpression contributes to genomic instability and tumorigenesis.
  • Aurora-A protein levels are tightly regulated by proteasome-dependent degradation pathways.
  • Ubiquitin-independent degradation pathways, mediated by factors like antizyme1 (Az1), also play a role in protein turnover.

Purpose of the Study:

  • To investigate the mechanism by which Aurora-A kinase interacting protein 1 (AURKAIP1) promotes Aurora-A degradation through a ubiquitin-independent pathway.
  • To determine the role of antizyme1 (Az1) in the regulation of Aurora-A protein stability.

Main Methods:

  • Ectopic and polyamine-induced expression of Az1 to assess its effect on Aurora-A levels.
  • Analysis of Aurora-A turnover using proteasome and ubiquitin dependency assays.
  • In vivo interaction studies between Az1, Aurora-A, and AURKAIP1 using co-immunoprecipitation.
  • Site-directed mutagenesis to identify critical interaction domains.

Main Results:

  • Ectopic or polyamine-induced Az1 expression reduced steady-state Aurora-A levels.
  • Az1-mediated Aurora-A degradation was proteasome-dependent but ubiquitin-independent.
  • Az1 directly interacts with Aurora-A, and this interaction is crucial for degradation.
  • AURKAIP1's ability to promote Aurora-A degradation was dependent on Az1 interaction and was abrogated by Az1 inhibitors.
  • AURKAIP1, Az1, and Aurora-A form a ternary complex, with AURKAIP1 enhancing Az1-Aurora-A binding.

Conclusions:

  • Antizyme1 (Az1) regulates Aurora-A protein stability via a ubiquitin-independent, proteasome-dependent mechanism.
  • AURKAIP1 acts upstream of Az1, enhancing its interaction with Aurora-A to facilitate proteasomal degradation.
  • This mechanism provides new insights into the regulation of Aurora-A and potential therapeutic targets in cancer.

More Related Videos

Tuning Degradation to Achieve Specific and Efficient Protein Depletion05:11

Tuning Degradation to Achieve Specific and Efficient Protein Depletion

Published on: July 20, 2019

Observing Mitotic Division and Dynamics in a Live Zebrafish Embryo10:10

Observing Mitotic Division and Dynamics in a Live Zebrafish Embryo

Published on: July 15, 2016

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...